NCR Graphs - All Cancers

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03AC02	BUTO-ASMA	G	Salbutamol - 100mcg	100mcg	Inhalation	237,860 L.L
R03AC02	BUTALIN	G	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	145,135 L.L
R03AL11	BREZTRI AEROSPHERE	B	Formoterol fumarate dihydrate - 5mcg, Glycopyrronium Bromide - 7.2mcg, Budesonide - 160mcg		Inhalation suspension	6,705,774 L.L
R03BA02	BUDENA	G	Budesonide - 50mcg/actuation	50mcg/actuation	Inhalation suspension	823,775 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
J01MA23	BAXDELA	B	Delafloxacin - 300mg	300mg	Injectable concentrate for solution	78,349,010 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	100,111,133 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	92,353,609 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	53,111,763 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	22,840,337 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	12,021,318 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrate for solution	41,821,582 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate), - 15mg	15mg	Injectable lyophilised powder for solution	2,109,833 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,561,486 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	27,354,631 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	47,481,122 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	19,610,153 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	24,934,922 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L

NCR graphs - Incidence rates by year